rs199813223
Positions:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_001077418.3(TMEM231):āc.710G>Cā(p.Arg237Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00147 in 1,612,202 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0013 ( 0 hom., cov: 31)
Exomes š: 0.0015 ( 4 hom. )
Consequence
TMEM231
NM_001077418.3 missense
NM_001077418.3 missense
Scores
12
7
Clinical Significance
Conservation
PhyloP100: 4.62
Genes affected
TMEM231 (HGNC:37234): (transmembrane protein 231) This gene encodes a transmembrane protein, which is a component of the B9 complex involved in the formation of the diffusion barrier between the cilia and plasma membrane. Mutations in this gene cause Joubert syndrome (JBTS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 16-75541410-C-G is Benign according to our data. Variant chr16-75541410-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 570416.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00132 (201/152194) while in subpopulation AMR AF= 0.00295 (45/15276). AF 95% confidence interval is 0.00226. There are 0 homozygotes in gnomad4. There are 104 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM231 | NM_001077418.3 | c.710G>C | p.Arg237Thr | missense_variant | 6/7 | ENST00000258173.11 | NP_001070886.1 | |
TMEM231 | NM_001077416.2 | c.869G>C | p.Arg290Thr | missense_variant | 5/6 | NP_001070884.2 | ||
TMEM231 | NR_074083.2 | n.876G>C | non_coding_transcript_exon_variant | 6/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM231 | ENST00000258173.11 | c.710G>C | p.Arg237Thr | missense_variant | 6/7 | 1 | NM_001077418.3 | ENSP00000258173.5 | ||
TMEM231 | ENST00000568377.5 | c.797G>C | p.Arg266Thr | missense_variant | 5/6 | 1 | ENSP00000476267.1 | |||
TMEM231 | ENST00000565067.5 | c.566G>C | p.Arg189Thr | missense_variant | 5/6 | 5 | ENSP00000457254.1 | |||
TMEM231 | ENST00000562410.5 | n.*512G>C | non_coding_transcript_exon_variant | 6/7 | 1 | ENSP00000454582.1 | ||||
TMEM231 | ENST00000570006.5 | n.*90G>C | non_coding_transcript_exon_variant | 6/7 | 5 | ENSP00000455520.1 | ||||
TMEM231 | ENST00000562410.5 | n.*512G>C | 3_prime_UTR_variant | 6/7 | 1 | ENSP00000454582.1 | ||||
TMEM231 | ENST00000570006.5 | n.*90G>C | 3_prime_UTR_variant | 6/7 | 5 | ENSP00000455520.1 | ||||
ENSG00000260092 | ENST00000460606.1 | n.157+1192G>C | intron_variant | 1 | ENSP00000457544.1 |
Frequencies
GnomAD3 genomes AF: 0.00132 AC: 201AN: 152194Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
201
AN:
152194
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00107 AC: 265AN: 247738Hom.: 0 AF XY: 0.000989 AC XY: 133AN XY: 134468
GnomAD3 exomes
AF:
AC:
265
AN:
247738
Hom.:
AF XY:
AC XY:
133
AN XY:
134468
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00149 AC: 2175AN: 1460008Hom.: 4 Cov.: 30 AF XY: 0.00141 AC XY: 1024AN XY: 726218
GnomAD4 exome
AF:
AC:
2175
AN:
1460008
Hom.:
Cov.:
30
AF XY:
AC XY:
1024
AN XY:
726218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00132 AC: 201AN: 152194Hom.: 0 Cov.: 31 AF XY: 0.00140 AC XY: 104AN XY: 74342
GnomAD4 genome
AF:
AC:
201
AN:
152194
Hom.:
Cov.:
31
AF XY:
AC XY:
104
AN XY:
74342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
8
ALSPAC
AF:
AC:
9
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
14
ExAC
AF:
AC:
129
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2022 | TMEM231: BP4 - |
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 13, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Joubert syndrome 20;C3809352:Meckel syndrome, type 11 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
TMEM231-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;.;D
REVEL
Uncertain
Sift
Uncertain
D;.;T
Sift4G
Uncertain
D;D;D
Polyphen
P;.;.
Vest4
MVP
MPC
0.043
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 45
Find out detailed SpliceAI scores and Pangolin per-transcript scores at